PTHR 是一种 G 蛋白偶联受体(GPCR),可调节钙磷平衡、骨形成和肾功能。PTHR 由甲状旁腺激素(PTH)、甲状旁腺激素相关肽(PTHrP)和 39 个残基的结节漏斗肽(TIP39)激活,从而激活 G 蛋白并启动下游信号,如 Gαs/cAMP/PKA 信号通路。PTHR 促进骨骼释放钙离子,增加肾脏对钙离子的重吸收,从而维持血钙平衡。PTHR 还通过促进肾脏磷排泄来降低血磷水平。PTHR 参与骨形成、软骨发育以及胰腺、牙齿和乳腺的发育。PTHR 有三种亚型,即 PTH1R、PTH2R 和 PTH3R。 PTH1R 对 PTH 和 PTHrP 有较高的亲和力,是钙稳态调节的主要受体。PTH2R 对 TIP39 有较高的亲和力,参与中枢神经系统的功能调节。PTH3R 主要在非哺乳类脊椎动物中表达,对 PTHrP 有较高的亲和力。PTHR 功能障碍可能导致 Blomstrand 致死性软骨发育不全、Ollier 病、Jansen 干骺端软骨发育不全、甲状旁腺功能减退、甲状旁腺功能亢进和骨质疏松症[1][2]。
PTHR is a G protein-coupled receptor (GPCR) that regulates calcium and phosphate homeostasis, bone formation, and renal function. PTHR is activated by PTH, PTH-related peptide (PTHrP), and tuberoinfundibular peptide of 39 residues (TIP39), which activates G-protein and initiates downstream signaling cascades such as Gαs/cAMP/PKA signaling pathway. PTHR promotes the release of calcium ions from bones and increases the kidneys' reabsorption of calcium ions, thereby maintaining blood calcium homeostasis. PTHR also reduces blood phosphorus levels by promoting renal phosphorus excretion. PTHR participates in bone formation, cartilage development, and the development of the pancreas, teeth and mammary glands. PTHR exists in three isoforms, PTH1R, PTH2R and PTH3R. PTH1R has a high affinity for PTH and PTHrP and is the main receptor for calcium homeostasis regulation. PTH2R has a high affinity for TIP39 and is involved in the functional regulation of the central nervous system. PTH3R is mainly expressed in non-mammalian vertebrates and has a higher affinity for PTHrP. PTHR dysfunction could lead to Blomstrand’s lethal chondroplasia, Ollier’s disease, Jansen’s metaphyseal chondroplasia, hypoparathyroidism, hyperparathyroidism and osteoporosis[1][2].
(Asn10,Leu11,D-Trp12)-pTH-Related Protein (7-34) amide (human, mouse, rat) 是一种有效的 PTH-1R 拮抗剂,且不显示任何部分激动剂活性。
DS37571084 是一种口服活性的强效甲状旁腺激素 1 型受体 (PTHR1) 拮抗剂,IC50 值为 0.17 μM,可用于甲状旁腺功能亢进症研究。
DS69910557 是一种具有口服活性的、有效的选择性人甲状旁腺激素受体 1 (hPTHR1) 拮抗剂,对 PTHR1 的拮抗活性 IC50 值为 0.08 μM,可用于甲状旁腺功能亢进症、恶性肿瘤高钙血症和骨质疏松症的研究。
PTHR1 antagonist 1 是一种 IC50 为 0.090 µM 的 PTHR1 拮抗剂,可用于钙代谢紊乱的研究。
© 2026 MolStrong. 保留所有权利。粤ICP备2023004355号
可通过CAS号进行批量搜索,一行一个CAS号